These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diabetic neuropathy and oxidative stress: therapeutic perspectives. Hosseini A; Abdollahi M Oxid Med Cell Longev; 2013; 2013():168039. PubMed ID: 23738033 [TBL] [Abstract][Full Text] [Related]
3. Insights into the pathogenesis and treatment of painful diabetic neuropathy. Greig M; Tesfaye S; Selvarajah D; Wilkinson ID Handb Clin Neurol; 2014; 126():559-78. PubMed ID: 25410244 [TBL] [Abstract][Full Text] [Related]
4. Burning through the pain: treatments for diabetic neuropathy. Javed S; Alam U; Malik RA Diabetes Obes Metab; 2015 Dec; 17(12):1115-25. PubMed ID: 26179288 [TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 pathway as a potential therapeutic target in diabetic peripheral neuropathy. Kellogg AP; Cheng HT; Pop-Busui R Curr Drug Targets; 2008 Jan; 9(1):68-76. PubMed ID: 18220714 [TBL] [Abstract][Full Text] [Related]
6. ER stress in diabetic peripheral neuropathy: A new therapeutic target. O'Brien PD; Hinder LM; Sakowski SA; Feldman EL Antioxid Redox Signal; 2014 Aug; 21(4):621-33. PubMed ID: 24382087 [TBL] [Abstract][Full Text] [Related]
7. Diabetic neuropathy: therapies on the horizon. Mahmood D; Singh BK; Akhtar M J Pharm Pharmacol; 2009 Sep; 61(9):1137-45. PubMed ID: 19703362 [TBL] [Abstract][Full Text] [Related]
8. State-of-the-art pharmacotherapy for diabetic neuropathy. Azmi S; Alam U; Burgess J; Malik RA Expert Opin Pharmacother; 2021 Jan; 22(1):55-68. PubMed ID: 32866410 [TBL] [Abstract][Full Text] [Related]
9. Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach? Farmer KL; Li C; Dobrowsky RT Pharmacol Rev; 2012 Oct; 64(4):880-900. PubMed ID: 22885705 [TBL] [Abstract][Full Text] [Related]
10. Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management. Jensen TS; Karlsson P; Gylfadottir SS; Andersen ST; Bennett DL; Tankisi H; Finnerup NB; Terkelsen AJ; Khan K; Themistocleous AC; Kristensen AG; Itani M; Sindrup SH; Andersen H; Charles M; Feldman EL; Callaghan BC Brain; 2021 Jul; 144(6):1632-1645. PubMed ID: 33711103 [TBL] [Abstract][Full Text] [Related]
11. Genetic Profiling of Sodium Channels in Diabetic Painful and Painless and Idiopathic Painful and Painless Neuropathies. Almomani R; Sopacua M; Marchi M; Ślęczkowska M; Lindsey P; de Greef BTA; Hoeijmakers JGJ; Salvi E; Merkies ISJ; Ferdousi M; Malik RA; Ziegler D; Derks KWJ; Boenhof G; Martinelli-Boneschi F; Cazzato D; Lombardi R; Dib-Hajj S; Waxman SG; Smeets HJM; Gerrits MM; Faber CG; Lauria G; On Behalf Of The Propane Study Group Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175987 [TBL] [Abstract][Full Text] [Related]
12. Understanding the Signaling Pathways Related to the Mechanism and Treatment of Diabetic Peripheral Neuropathy. Tang HY; Jiang AJ; Ma JL; Wang FJ; Shen GM Endocrinology; 2019 Sep; 160(9):2119-2127. PubMed ID: 31318414 [TBL] [Abstract][Full Text] [Related]
13. Expert opinion on screening, diagnosis and management of diabetic peripheral neuropathy: a multidisciplinary approach. Atmaca A; Ketenci A; Sahin I; Sengun IS; Oner RI; Erdem Tilki H; Adas M; Soyleli H; Demir T Front Endocrinol (Lausanne); 2024; 15():1380929. PubMed ID: 38952393 [TBL] [Abstract][Full Text] [Related]